The Jackson Laboratory;Indiana University Research and Technology Corporation
发明人:
Howell, Gareth,Sasner, Michael,Carter, Gregory,Lamb, Bruce
申请号：
AU2018239433
公开号：
AU2018239433A1
申请日:
2018.03.21
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Genetically modified mice characterized by one or more symptoms or signs associated with expression of human APOE4p and mouse Trem2p and relevant to non- familial late-onset Alzheimer's disease are provided wherein the genome of the mouse includes: 1) a DNA sequence encoding a human APOE4 protein (APOE4p) operably linked to a promoter； and 2) a DNA sequence encoding a mouse Trem2 protein having a mutation p,R47H (Trem2p) operably linked to a promoter, such that the mouse expresses human APOE4p and mouse Trem2p. Methods ace provided for screening for a compound for use in the treatment of Alzheimer's disease using such genetically modified mice.
